Workit Health, the nation’s leading provider of virtual substance use disorder treatment, today announced a $118 million round of investment led by New York-based global private equity and venture capital firm Insight Partners, with participation from CVS Health Ventures, FirstMark Capital, BCBS Venture Fund, and 3L Capital. This investment comes in the wake of heightened demand for telemedicine options during the COVID-19 pandemic, resulting in a 400% increase in Workit Health membership over the past 18 months. The funding will be used to accelerate Workit Health’s growth into new markets, as well as expanding its primary and psychiatric care offerings, bringing effective care for substance use and co-occurring conditions to people from the privacy of their own home.

“Workit is at the forefront of massive acceleration in telemedicine adoption, which is key to solving the overdose crisis that was exacerbated by COVID-19. The risk factors associated with substance use have dramatically increased,” said Lisa McLaughlin, Workit Health’s Co-CEO. “This latest funding round helps us grow our relationship-based, telehealth-first, value-based approach into new regions that are in desperate need of simple and trusted solutions like Workit.”


Read the full press release.